Oramed Pharmaceuticals Inc.
NASDAQ: ORMP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Nadav Kidron
- Employees
- 13
- Headquarters
- New York City, United States
- IPO year
- 2007
- Market cap
- $176.0M
- Website
- https://www.oramed.com
Loading ORMP…
Loading profile data…Frequently asked questions about ORMP
What does Oramed Pharmaceuticals Inc. (ORMP) do?
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an o...
Where does ORMP trade?
Oramed Pharmaceuticals Inc. (ORMP) trades on the NASDAQ Capital Market.
What sector is ORMP in?
Oramed Pharmaceuticals Inc. (ORMP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oramed Pharmaceuticals Inc.?
Nadav Kidron is the chief executive officer of Oramed Pharmaceuticals Inc. (ORMP).
Where is Oramed Pharmaceuticals Inc. headquartered?
Oramed Pharmaceuticals Inc. is headquartered in United States.
Does ORMP pay a dividend?
Yes — Oramed Pharmaceuticals Inc. (ORMP) paid a trailing twelve-month dividend of USD 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ORMP go public?
Oramed Pharmaceuticals Inc. (ORMP) completed its initial public offering in 2007.